Tag: livanova

COVID-19: LivaNova can modify indications of its cardiopulmonary products to help...

LivaNova has announced that several of its cardiopulmonary products are can now be used in the USA for extracorporeal membrane oxygenation (ECMO) therapy for...

Positive results for LivaNova’s Perceval sutureless valve

Three newly published studies highlight the safety, efficacy, and economic advantage of the Pervecal sutureless aortic valve (LivaNova). The results from the Perceval Aortic...

PRECLUDE study of Caisson TMVI system concludes

LivaNova has announced the conclusion of the PRELUDE feasibility study for its Caisson transcatheter mitral valve implantation (TMVI) system. The PRELUDE first-in-human study evaluated...

LivaNova to buy TandemLife

LivaNova has entered into an agreement to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions. A press release reports...

Optiflow arterial cannulae family launched onto the USA

LivaNova has received FDA 510(k) clearance for the US market launch of its Optiflow arterial cannulae family.  A press release reports that the Optiflow...

New literature review highlights that Perceval sutureless aortic valve is safe

Corey Adams (Health Science Center, St John’s, Canada) and others report in the latest issue of Innovations that the Perceval sutureless aortic valve (LivaNova)...

LivaNova’s Perceval sutureless valve awarded Centers for Medicare and Medicaid add-on...

LivaNova’s Perceval sutureless aortic heart valve has received approval from the US Centers for Medicare and Medicaid Services (CMS) for a New Technology Add-on...

LivaNova acquires Caisson Interventional

LivaNova has announced it has acquired the remaining outstanding interests in Caisson Interventional in support of its strategic growth initiatives. Based in Maple Grove...

New data reaffirms value of Perceval for aortic valve replacement in...

LivaNova has announced the presentation of data from multiple studies demonstrating the safety and the effectiveness of the Perceval sutureless valve for aortic valve...

LivaNova to delist from London Stock Exchange

LivaNova has applied for the voluntary cancellation of its standard listing of ordinary shares with the United Kingdom Listing Authority and to the London...